title: Efficacy and safety of zotepine for patients with treatment-resistant schizophrenia.
authors.forename: K
authors.initials: K
authors.lastname: Hashimoto
authors.forename: T
authors.initials: T
authors.lastname: Sudo
authors.forename: M
authors.initials: M
authors.lastname: Hirano
authors.forename: H
authors.initials: H
authors.lastname: Motomura
authors.forename: K
authors.initials: K
authors.lastname: Tagawa
authors.forename: S
authors.initials: S
authors.lastname: Nashiro
authors.forename: K
authors.initials: K
authors.lastname: Uemura
authors.forename: S
authors.initials: S
authors.lastname: Yoshimoto
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D003988:Dibenzothiepins / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D004351:Drug Resistance; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia / Q000188:drug therapy*; D016896:Treatment Outcome
chemical_list: D014150:Antipsychotic Agents; D003988:Dibenzothiepins; C022172:zotepine